Back to Top

About

Peter qualified in medicine at Westminster Medical School. Having first worked as a physician at The Whittington Hospital and KCH, he trained in psychiatry at the Maudsley Hospital and epidemiology at the London School of Hygiene. He has been Professor of Psychiatry at Cambridge since 2000, Head of Department of Psychiatry from 2000-2014, and Deputy Head of the Clinical School since 2014. He has been a NIHR CLARHC Director since 2008 and is a NIHR Senior Investigator. Peter’s research interests are in the epidemiology of mental illness, particularly early life determinants, and in evaluation of effective interventions at the individual and system level. Clinically he co-led the award winning CAMEO.nhs.uk early intervention service until taking on his NIHR responsibilities in the Collaboration for Leadership in Applied Health Research & Care East of England. Peter studied medicine at KCL and Westminster Medical School. He practised hospital medicine for three years before tasting psychiatry at the Maudsley Hospital and Institute of Psychiatry where he remained for nine years becoming an honorary consultant and senior lecturer; three of these were spent as an MRC Training Fellow and reading Epidemiology at the London School of Hygiene and Tropical Medicine. He was seconded half-time to the Department of Health 1993-1996 where he led the Policy Research Programme Mental Health Research Initiative and convened the multi-party group that led to the reduction in paracetamol pack size as part of the national suicide prevention policy. After five years at the University of Nottingham, four as Professor of Psychiatry and Community Mental Health, Peter moved to Cambridge in 2000 as Head of Department of Psychiatry and honorary consultant psychiatrist with the Cambridgeshire & Peterborough NHS Foundation Trust.; he was co-founder of the award-winning Cameo early intervention team for young people who experience a first episode of psychosis. In 2014 he stepped-down as Head of Department to become Deputy Head of the School of Clinical Medicine. Peter was elected a Fellow of Wolfson College in 2003. He is a Director of Cambridge University Health Partners, and Director of the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care for the East of England (CLAHRC EoE). He is a trustee of MQ: transforming mental health, a research charity endowed by the Wellcome Trust, and is an NIHR Senior Investigator Emeritus. Peter has been President of IEPA Early Intervention in Mental Health 2016-2018.

View more >>

Skills

Experience

Professor Emeritus & Clinical Director of Research

University of Cambridge

Oct-2000 to Present
Professor of psychiatry & community mental health

University of Nottingham

Sep-1995 to Sep-2000
Senior Lecturer & honorary consultant psychiatrist

Institute of Psychiatry, Psychology & Neuroscience (IoPPN)

Sep-1991 to Sep-1995
Registrar & Senior Registrar

Bethlem Royal Hospital

Oct-1987 to Sep-1991
Medical Registrar

King’s College Hospital NHS Foundation Trust

Feb-1987 to Sep-1987
Medical SHO

Whittington Hospital

Feb-1986 to Jan-1987
Casualty Officer

Chelsea and Westminster Hospital

Feb-1985 to Jan-1986
House Surgeon

Royal Surrey County Hospital

Aug-1984 to Jan-1985
Honorary consultant psychiatrist

Cambridgeshire and Peterborough NHS Foundation Trust (CPFT)

Oct-2000 to Dec-2024
Governing Body Fellow

Wolfson College, Cambridge

Mar-2003 to Dec-2024

Education

London School of Hygiene & Tropical Medicine (LSHTM)

M.Sc. in Epidemiology

Passout Year: 1992
Westminster Hospital Medical School (WHMS)

MBBS in Medicine

Passout Year: 1984
King's College London

B.Sc. in Neurobiology and Anatomy

Passout Year: 1981

Publication

Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients

We aimed to investigate long-term outcomes in psychotic major depression patients compared to schizophrenia and bipolar/manic psychosis patients, in an incidence sample, while accounting for...

Body mass index in the middle-aged offspring of parents with severe mental illness

Background People with severe mental illness (SMI) have an elevated risk of obesity but the causes and mechanisms are unclear. We explored the familial association between parental SMI and ...

Research Article
  • dott image Richard A.I. Bethlehem
  • dott image May, 2022

Sexually divergent development of depression-related brain networks during healthy human adolescence

Sexual differences in human brain development could be relevant to sex differences in the incidence of depression during adolescence. We tested for sex differences in parameters of normative...

Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and c...

Background First episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether thi...

Preference uncertainty accounts for developmental effects on susceptibility to peer influence in adolescence

Adolescents are prone to social influence from peers, with implications for development, both adaptive and maladaptive. Here, using a computer-based paradigm, we replicate a cross-sectional ...

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study

Background Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder. However, the evidence is mixed on whether any pattern of cannabis u...

Neurological Signs at the First Psychotic Episode as Correlates of Long-Term Outcome: Results From the AESOP-10 Study

Minor neurological signs are subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts present in excess in the early stages of psychosis. Still, it re...

Advancing methodology for scoping reviews: recommendations arising from a scoping literature review (SLR) to inform transformation of Children and Ado...

Background There is consensus that health services commissioning and clinical practice should be driven by scientific evidence. However, workload pressures, accessibility of peer reviewed p...

Research Article
  • dott image Graham Murray
  • dott image August, 2020

Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizo...

Background Schizophrenia is a complex disorder in which the causal relations between risk genes and observed clinical symptoms are not well understood and the explanatory gap is too wide to...

Schizotypy-Related Magnetization of Cortex in Healthy Adolescence Is Colocated With Expression of Schizophrenia-Related Genes

Background Genetic risk is thought to drive clinical variation on a spectrum of schizophrenia-like traits, but the underlying changes in brain structure that mechanistically link genomic va...

Projects

Jan-2024 to Jan-2024

Early Psychosis Multi-arm Multi-stage Platform Trial (PUMA)

GBP 1,390,427

Funded by Wellcome (London, GB)

Establishing an adaptive trials platform for early psychosis. CI Belinda Lennox, University of Oxford.
Jan-2023 to Dec-2024

Cogs AI - Social - Emotional Screener for Neurodiverse Children

GBP 414,918

Funded by Innovate UK (Swindon, GB)

Academic partner (and applicant) with Jan Stochl applying adaptive testing technology to a screening app. Cogs AI is the academic partner.
May-2024 to Dec-2024

Market research for Cambridge Adaptive Testing Ltd.

GBP 20,000

Funded by University of Cambridge

Apr-2023 to Apr-2023

Access to Expertise for Cambridge Adaptive Testing - Mental health screening platforms – medical d...

GBP 6,144

Funded by Wellcome Trust (London, GB)

Administered by Cambridge Academy of Therapeutic Sciences

Conference/Seminar/STTP/FDP/Symposium/Workshop

Conference
  • dott image Dec 2018

Predicting Population-level Need for Early Treatment Programmes in First Episode Psychosis: The Advanced Psychiatric MAPping Translated into Innovations for Care [PsyMaptic-A] Study

Hosted By:

Wiley ,

Hoboken, New Jersey, United States

Membership

dott image
Trustee

Mental Health Research UK

From year 2019 to Present
dott image
Emeritus Professor of Psychiatry

University of Cambridge

From year 2021 to Present

Patent

  • dott image Medical & Health Science
Model directed sampling system
Assignee:

SYSTEMS & TECHNOLOGY RESEARCH LLC System & Technology Research LLC

Filing Country:

United States

Filing Month:

Mar 2016

Application No:

15/059,838

Patent No:

US20160259844A1

Publication status:

Published

Publication Date:

Sep 2016

Inventor(s): Kirill Trapeznikov, Gary Richard Condon, Eric Kimball Jones, Peter Brunson Jones, Nicholas John Pioch
  • dott image Medical & Health Science
Systems and Methods for Managing Documents and Other Electronic Content
Assignee:

Intertrust Technologies Corp

Filing Country:

United States

Filing Month:

Mar 2014

Application No:

US14/229,650

Patent No:

US20140298207A1

Publication status:

Published

Publication Date:

Oct 2014

Inventor(s): Gadi Ittah, David P. Maher, Daniel Vickery, Peter Jones, Sung Chun, Tauseef Bashir
  • dott image Medical & Health Science
Matched mailer form
Assignee:

Moore Business Forms Inc

Filing Country:

United States

Filing Month:

Dec 1992

Application No:

US07/835,481

Patent No:

US5174491A

Publication status:

Published

Publication Date:

Dec 1992

Inventor(s): Donald Taylor, Phillip Jones, Julie Ann Zarth